NCT06998511

Brief Summary

The Iinterdisciplinary collaborative care model combined with family empowerment (ICCM-FE) intervention based on the COM-B model can effectively improve blood pressure and glucose control in patients with comorbid hypertension and diabetes, enhance their quality of life and psychosocial adaptation, and significantly increase patient satisfaction with nursing care. This intervention has important clinical application value.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
187

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 7, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 6, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

8 months

First QC Date

May 6, 2025

Last Update Submit

May 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood Pressure Control

    Change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) from baseline to 6 months post-intervention.

    Baseline and 6 months.

Secondary Outcomes (4)

  • Quality of Life (SF-36 Scale)

    Baseline and 6 months

  • Psychosocial Adaptation (PAIS-SR Scale)

    Baseline and 6 months.

  • Self-Efficacy (GSES Scale)

    Baseline and 6 months.

  • Nursing Satisfaction (NSNS Scale)

    6 months.

Other Outcomes (1)

  • Adherence to Intervention

    Monthly for 6 months.

Study Arms (2)

routine nursing intervention

OTHER

The control group received routine nursing intervention, including basic drug treatment, diet and exercise guidance, psychological counseling, etc.

Other: routine nursing intervention

interdisciplinary collaborative care and family empowerment (ICCM-FE) intervention

OTHER

The observation group received interdisciplinary collaborative care and family empowerment (ICCM-FE) intervention based on the COM-B model on the basis of routine care.

Other: interdisciplinary collaborative care and family empowerment (ICCM-FE) intervention

Interventions

The observation group received interdisciplinary collaborative care and family empowerment (ICCM-FE) intervention based on the COM-B model on the basis of routine care.

interdisciplinary collaborative care and family empowerment (ICCM-FE) intervention

The control group received routine nursing intervention, including basic drug treatment, diet and exercise guidance, psychological counseling, etc.

routine nursing intervention

Eligibility Criteria

Age36 Years - 58 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients met the diagnostic criteria for hypertension and diabetes as specified in the 《2020 International Society of Hypertension Global Hypertension Practice Guidelines》and the 《2020 American Diabetes Association (ADA) Standards of Medical Care in Diabetes》 ;
  • had at least one caregiver, and both the patient and caregiver had basic communication and comprehension abilities to cooperate with the nursing interventions and complete the questionnaires;
  • voluntarily participated in the study and signed an informed consent form;
  • complete follow-up records.

You may not qualify if:

  • severe organ dysfunction or mental illness;
  • malignancies, severe cardiovascular events (e.g., stroke, myocardial infarction);
  • severe hepatic or renal impairment;
  • poor adherence or life expectancy less than 1 year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science

Xiangyang, 441138, China

Location

MeSH Terms

Conditions

HypertensionDiabetes Mellitus

Interventions

Methods

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 6, 2025

First Posted

May 31, 2025

Study Start

January 7, 2023

Primary Completion

September 5, 2023

Study Completion

March 16, 2024

Last Updated

May 31, 2025

Record last verified: 2025-05

Locations